Array Biopharma, Inc. (ARRY) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $7.17 --0%
EPS Growth %: -52.0%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
PKE, LNN, More
EPS Growth %: -52.0%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
On Monday, Array Biopharma, Inc. (NASDAQ: ARRY) reported Q1 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $15.8 million versus the consensus estimate of $16.7 million.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Goldman Sachs Downgrades SkyWest (SKYW) to Neutral
- UBS Upgrades Watches of Switzerland (WOSG:LN) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
